Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Internal US FDA Disagreements Feature In One-Quarter Of Novel Approvals

Aug 11 2020

• By Bridget Silverman

disagreement thumbs up and thumbs down — Researchers question whether integrated review documents will adequately reflect agency disagreements. • Source: Shutterstock

Related Content

FDA Changed Course On <em>Zontivity </em>Because Of Skepticism Of Subgroups At High Levels

Sep 01 2014

“Marginal” Mortality Benefit Belongs In <em>Eliquis</em>’ Label, But Not The Indication Statement, FDA Says

Jun 18 2013

<em>Brilinta</em> Review Sparks War Of Words Between FDA Cardio-Renal Division’s Marciniak, Stockbridge

Jan 01 2012

US FDA's Integrated Review Doc: Industry Says Don't Lose The Detail

Sep 02 2019

<em>Savaysa</em> A-Fib Data Led To Conflicting FDA Views On Dose, Population

Apr 20 2015

Additional Topics

United States Approvals Drug Review FDA Regulation Drug Review Profile BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window